Prenatal and progressive coenzyme Q10 administration to mitigate muscle dysfunction in mitochondrial...
Prenatal and progressive coenzyme Q10 administration to mitigate muscle dysfunction in mitochondrial disease
About this item
Full title
Author / Creator
Publisher
Heidelberg: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Heidelberg: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
ADCK genes encode aarF domain‐containing mitochondrial kinases involved in coenzyme Q (CoQ) biosynthesis and regulation. Haploinsufficiency of ADCK2 in humans leads to adult‐onset physical incapacity with reduced mitochondrial CoQ levels in skeletal muscle, resulting in mitochondrial myopathy and alterations in fatty acid β‐oxidation....
Alternative Titles
Full title
Prenatal and progressive coenzyme Q10 administration to mitigate muscle dysfunction in mitochondrial disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_7c71afc86b444911a4efedc1c6edb74c
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7c71afc86b444911a4efedc1c6edb74c
Other Identifiers
ISSN
2190-5991,2190-6009
E-ISSN
2190-6009
DOI
10.1002/jcsm.13574
